Summary
The global Intramuscular Drug Delivery Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019.
Intramuscular drug delivery has been one of the leading methods of delivering medications throughout the world for decades. As advances in medical delivery continue to progress, the need for a safe and effective method of delivering medications has increased as well.
The most common form of intramuscular drug delivery is injection. In this process, an injection of medication is given directly into the muscle. This method is used in many cases to deliver both prescription and over-the-counter medications. The other type of intramuscular delivery is by means of an aerosol spray. These medications are delivered into the muscles by inhalation. This method is less effective than injectable drugs because the lungs are not directly exposed to the medication.
The growing prevalence of chronic disease around the globe coupled with the increasing use of biologics is driving the growth of the intramuscular drug delivery market. The rising adoption of self-injection due to the growing prevalence of diabetes is also projected to augment the growth of the market. According to the American Diabetes Association, in 2018, 34.2 million Americans, or 10.5% of the population, had diabetes. Nearly 1.6 million Americans have type 1 diabetes, including about 187,000 children and adolescents. 1.5 million Americans are diagnosed with diabetes every year. Moreover, growing technological advancement in drug delivery devices is again projected to foster the growth of the intramuscular drug delivery market.
North America is projected to gain significant growth over the forecast period and this is attributed to the strong presence of well-established healthcare infrastructure coupled with the high prevalence of the chronic disease. According to the National Health Council, chronic diseases affect approximately 133 million Americans, representing more than 40% of the total population of this country. By 2020, that number is projected to grow to an estimated 157 million, with 81 million having multiple conditions.
Key Developments:
- In October 2019, West Pharmaceutical Services, Inc. has introduced two new product offerings, the NovaPure 3mL Cartridge components, and the SmartDose Gen. II 10mL injector.
- In October 2019, BD (Becton, Dickinson, and Company) has launched the BD Intevi 1mL two-step disposable autoinjector, a device combining autoinjector and pre-fillable syringe in one integrated system.
- In June 2020, West Pharmaceutical Services, Inc., a global provider of innovative solutions for injectable drug administration, has introduced the AccelTRA ready to sterilize (RTS) and ready to use (RTU) product line in the Indian market
The Intramuscular Drug Delivery Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Intramuscular Drug Delivery Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.
The Key Manufacturers covered in this Report:-
- Antares Pharma
- Eli Lily
- Galaxo
- HMD pharmaceuticals
- Inovio Pharmaceuticals
- Merck
- Novartis
- Pacira Pharmaceuticals
- Pfizer
- Pharmajet
- Teva Pharmaceutical
By the Product Type, the market is primarily segmented into:
- Drug Molecule
- Delivery Devices
By Applications, the market is segmented into:
- Infectious Disease
- Oncology
- Autoimmune Diseases
The Report covers the following Regions:
- North America
- United States
- Canada
- Mexico
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Central & South America
- Middle East & Africa
- Turkey
- GCC Countries
- Egypt
- South Africa
Objective of the Intramuscular Drug Delivery Market Report:
- To assess the size of the market by value and volume
- Analyze the Intramuscular Drug Delivery Market in terms of regions and major countries
- Highlight recent developments and trends in the market
- Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
- Determine share of the Intramuscular Drug Delivery Market in terms of various segments such as by product type, application, and end-user
- Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
- Discuss major factors that impact growth of the Intramuscular Drug Delivery Market
The Intramuscular Drug Delivery Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Intramuscular Drug Delivery Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders:
- Material suppliers/wholesalers
- Market Distributors/traders
- Regulatory bodies
- Research organizations, and consulting firms
- Commercial research & developments (R&D)
- Trade associations and industry bodies
- Importers and exporters
- End-use industries
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
Request Discount 
Inquire Before Buy
